Putnam BioRevolution ETF Rating $29.68 +0.35 (+1.19%) (As of 12/20/2024 04:33 PM ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatings Putnam BioRevolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SYNB Aggregate RatingModerate Buy 2.79Holdings in SYNB have an aggregate rating of Moderate Buy based on 546 analyst ratings issued in the past year covering 31 companies (88.3% of the portfolio).SYNB Aggregate Price Target$29.68High Prediction$29.68Average Prediction$29.68Low Prediction$29.68Holdings in SYNB have an aggregate price target of $29.68 and a range of $29.68 to $29.68 covering 31 companies (88.3% of the portfolio).SYNB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy27 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Putnam BioRevolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 31 SYNB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.68%TMOThermo Fisher Scientific$524.05+1.4%4.7588 of 5 stars2.86$652.30 24.5%216.29%DHRDanaher$228.55+1.1%4.8994 of 5 stars2.79$288.21 26.1%19Analyst ForecastHigh Trading Volume6.13%BIOBio-Rad Laboratories$327.47+0.5%4.3424 of 5 stars2.60$394.20 20.4%5Analyst RevisionPositive NewsHigh Trading Volume6.01%NVDANVIDIA$134.70+3.1%4.9489 of 5 stars2.95$164.15 21.9%43Insider Trade5.11%ABBVAbbVie$175.58+2.4%4.9334 of 5 stars2.88$205.70 17.2%24Analyst ForecastInsider TradeHigh Trading Volume4.79%CTVACorteva$57.48+2.4%4.5608 of 5 stars2.68$65.41 13.8%19Analyst ForecastHigh Trading Volume3.80%AZNAstraZeneca$65.35+1.4%4.0456 of 5 stars2.91$89.75 37.3%113.75%LLYEli Lilly and Company$767.76+1.3%4.9926 of 5 stars2.81$1,002.22 30.5%21Gap UpHigh Trading Volume3.73%GOOGLAlphabet$191.41+1.5%3.6847 of 5 stars2.93$206.69 8.0%42Analyst ForecastInsider TradePositive NewsHigh Trading Volume3.64%EXASExact Sciences$59.40+5.9%4.4883 of 5 stars2.94$72.94 22.8%183.59%DDDuPont de Nemours$77.28+0.6%4.748 of 5 stars2.54$95.25 23.3%13Analyst ForecastShort Interest ↓3.29%ASNDAscendis Pharma A/S$136.38-1.0%3.1312 of 5 stars2.92$191.77 40.6%133.03%REGNRegeneron Pharmaceuticals$701.85-0.9%4.6634 of 5 stars2.70$1,052.90 50.0%23Analyst ForecastHigh Trading Volume2.90%ZTSZoetis$164.84+0.8%4.6042 of 5 stars3.09$215.22 30.6%11High Trading Volume2.79%DARDarling Ingredients$33.06-1.7%4.4255 of 5 stars2.78$53.44 61.7%9Positive News2.53%CDNSCadence Design Systems$301.47+0.5%4.3996 of 5 stars2.77$327.92 8.8%13Insider Trade2.47%AVTRAvantor$21.21+0.9%4.9283 of 5 stars2.85$27.69 30.6%132.08%NGVTIngevity$40.80+0.1%3.7629 of 5 stars2.50$52.17 27.9%6High Trading Volume1.79%ONONON$57.14+3.6%1.6681 of 5 stars2.83$56.77 -0.6%24Analyst ForecastPositive News1.63%PPGPPG Industries$120.21+0.6%4.7004 of 5 stars2.59$149.29 24.2%17Analyst ForecastHigh Trading Volume1.49%TECHBio-Techne$73.17+2.5%4.6339 of 5 stars2.63$82.00 12.1%8High Trading Volume1.48%ARGXargenx$623.82-0.4%3.0025 of 5 stars2.91$639.78 2.6%22Analyst ForecastShort Interest ↓Positive News1.45%BMRNBioMarin Pharmaceutical$65.66+1.0%4.9845 of 5 stars2.74$94.20 43.5%23Positive NewsHigh Trading Volume1.44%VRTXVertex Pharmaceuticals$397.27+0.2%4.7433 of 5 stars2.52$499.77 25.8%31Analyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume1.39%TWSTTwist Bioscience$47.94+9.9%2.5533 of 5 stars2.70$51.90 8.3%10High Trading Volume1.08%MEDPMedpace$337.28+0.6%4.6219 of 5 stars2.45$380.56 12.8%11High Trading Volume1.08%ALNYAlnylam Pharmaceuticals$245.44+2.8%4.4119 of 5 stars2.71$298.09 21.5%24Analyst Upgrade1.03%RCKTRocket Pharmaceuticals$11.56+1.9%4.8498 of 5 stars2.92$48.80 322.1%12Analyst ForecastHigh Trading Volume0.99%BGBunge Global$79.10+1.5%4.7796 of 5 stars2.78$118.00 49.2%9Positive NewsHigh Trading Volume0.47%LEGNLegend Biotech$34.08+0.2%1.5471 of 5 stars3.00$81.54 139.3%130.39%CRSPCRISPR Therapeutics$40.72+0.8%2.5514 of 5 stars2.44$77.93 91.4%18Analyst ForecastHigh Trading Volume This page (NYSEARCA:SYNB) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
